Aurinia Pharmaceuticals Inc (AUPH)

7.80 +0.03 (+0.39%) USD  |  NASDAQ  |  Jun 23, 12:28
More

Aurinia Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Edesa Biotech Inc --
Lexaria Bioscience Corp --
Xenon Pharmaceuticals Inc --
ESSA Pharma Inc --
ProMIS Neurosciences Inc --